Lv11
30 积分 2023-11-19 加入
CD96 as a therapeutic target for CAR T cell therapy in acute myeloid leukemia
3小时前
待确认
SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial
18天前
已完结
Glucocorticoid receptor signaling: crosstalk with inflammation
1个月前
已完结
Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study
1个月前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
1个月前
已完结
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma
1个月前
已完结
Emerging therapeutic strategies for mature T-cell and natural killer-cell lymphomas
1个月前
已完结
Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology
1个月前
已完结
Hemophagocytic Lymphohistiocytosis
1个月前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
3个月前
已完结
皖公网安备34019202002308
